rxstat › Prices in Saskatchewan › Tildrakizumab
Tildrakizumab (Ilumya) price and coverage in Saskatchewan
Tildrakizumab 100 mg/ml solution lists at $49.35 per billed unit in Saskatchewan on the Saskatchewan Drug Plan's price list (Nov 1, 2026), before the pharmacy's dispensing fee.
Tildrakizumab is covered by the Saskatchewan Drug Plan only under Exception Drug Status (EDS): your prescriber has to request coverage, and it applies to patients who meet set criteria.
Price by strength in Saskatchewan
| Strength and form | Lowest price | Brand |
|---|---|---|
| 100 mg/ml Solution2 products · special approval | $49.35/unit | – |
All 2 products listed in Saskatchewan
| Product | Price | Coverage |
|---|---|---|
| 100 mg/ml Solution | ||
| IlumyaSUN · DIN 02516098 | $49.35/unit | Special approval |
| IlumyaSUN · DIN 02558904 | $49.35/unit | Special approval |
What you'll pay at the pharmacy
These are the prices the Saskatchewan Drug Plan lists for the drug itself. The pharmacy adds a dispensing fee and sometimes a markup, so paying cash costs more. If you have coverage, your share depends on your deductible and co-pay.
Shortage status
No active shortage is reported for Tildrakizumab in Canada. Full drug page.
Tildrakizumab price in other provinces
Common questions
How much does Tildrakizumab cost in Saskatchewan?
Tildrakizumab 100 mg/ml solution lists at $49.35 per billed unit in Saskatchewan on the Saskatchewan Drug Plan's price list (Nov 1, 2026), before the pharmacy's dispensing fee.
Is Tildrakizumab covered in Saskatchewan?
Tildrakizumab is covered by the Saskatchewan Drug Plan only under Exception Drug Status (EDS): your prescriber has to request coverage, and it applies to patients who meet set criteria.
Is Tildrakizumab cheaper in another province?
For 100 mg/ml solution, listed prices run from $4935.00 to $4935.00 across 3 provinces. Public plans only cover their own residents, though.
Source: Saskatchewan Drug Plan Formulary (Nov 1, 2026). Public plan list prices per unit, before pharmacy fees and markup. This page is not medical advice.